Doyle John Brendan bought CGTX
July 29, 2025 · Form 4 insider transaction
Doyle John Brendan bought 30,000 shares of Cognition Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderDoyle John Brendan
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 29, 2025
Filing dateJuly 31, 2025
Shares owned after434,710
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025.